|
|
|
Insider
Information: |
Haughey Thomas |
Relationship: |
Director |
City: |
Woodcliff Lake |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
51,526 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,465,124 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
51,526 |
|
|
Total
Value |
$3,465,124 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Par Pharmaceutical Companies Inc |
PRX |
President, Director |
2012-09-28 |
0 |
2012-09-28 |
0 |
Premium* |
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2024-05-21 |
51,526 |
2018-06-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, Gen Counsel |
|
2010-03-01 |
4 |
S |
$25.08 |
$786,545 |
D/D |
(31,301) |
139,480 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, Gen Counsel |
|
2010-03-02 |
4 |
S |
$25.45 |
$273,834 |
D/D |
(10,756) |
128,724 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-05-09 |
4 |
S |
$34.47 |
$3,447 |
D/D |
(100) |
84,455 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-05-09 |
4 |
S |
$34.45 |
$3,720,200 |
D/D |
(106,493) |
79,055 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-05-10 |
4 |
S |
$35.45 |
$952,727 |
D/D |
(26,800) |
79,055 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, Gen Counsel |
|
2010-03-01 |
4 |
OE |
$13.06 |
$349,995 |
D/D |
26,799 |
170,781 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-05-09 |
4 |
OE |
$10.99 |
$753,815 |
D/D |
68,591 |
185,648 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-05-10 |
4 |
OE |
$13.06 |
$350,008 |
D/D |
26,800 |
105,855 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, General Counsel, Secy. |
|
2008-03-24 |
4 |
D |
$18.37 |
$43,335 |
D/D |
(2,359) |
130,812 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2008-12-22 |
4 |
D |
$12.43 |
$25,270 |
D/D |
(2,033) |
175,775 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Cnsl |
|
2009-01-06 |
4 |
D |
$13.59 |
$23,647 |
D/D |
(1,740) |
174,035 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Cnsl |
|
2009-01-09 |
4 |
D |
$12.83 |
$35,193 |
D/D |
(2,743) |
171,292 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Cnsl |
|
2009-01-12 |
4 |
D |
$12.59 |
$12,804 |
D/D |
(1,017) |
170,275 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2009-03-23 |
4 |
D |
$11.19 |
$26,397 |
D/D |
(2,359) |
167,916 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Coun |
|
2009-12-22 |
4 |
D |
$26.04 |
$52,939 |
D/D |
(2,033) |
134,883 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Coun |
|
2010-01-11 |
4 |
D |
$25.80 |
$93,448 |
D/D |
(3,622) |
143,982 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2010-03-22 |
4 |
D |
$25.09 |
$59,187 |
D/D |
(2,359) |
126,365 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2010-11-18 |
4 |
D |
$37.72 |
$497,112 |
D/D |
(13,179) |
113,186 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Cnsl |
|
2010-12-20 |
4 |
D |
$38.26 |
$101,006 |
D/D |
(2,640) |
110,546 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-01-04 |
4 |
D |
$39.79 |
$42,058 |
D/D |
(1,057) |
109,489 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-01-11 |
4 |
D |
$35.98 |
$714,743 |
D/D |
(19,865) |
120,097 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
|
2011-03-22 |
4 |
D |
$29.00 |
$88,856 |
D/D |
(3,064) |
117,057 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
President |
|
2011-11-21 |
4 |
D |
$29.56 |
$194,771 |
D/D |
(6,589) |
72,466 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
President |
|
2012-01-04 |
4 |
D |
$32.17 |
$34,004 |
D/D |
(1,057) |
71,409 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
President |
|
2012-01-06 |
4 |
D |
$34.01 |
$25,303 |
D/D |
(744) |
70,665 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|